1l8k

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Protein-tyrosine phosphatase 1B (PTP1B) has recently received much, attention as a potential drug target in type 2 diabetes. This has in, particular been spurred by the finding that PTP1B knockout mice show, increased insulin sensitivity and resistance to diet-induced obesity., Surprisingly, the highly homologous T cell protein-tyrosine phosphatase, (TC-PTP) has received much less attention, and no x-ray structure has been, provided. We have previously co-crystallized PTP1B with a number of low, molecular weight inhibitors that inhibit TC-PTP with similar efficiency., Unexpectedly, we were not able to co-crystallize TC-PTP with the same set, of inhibitors. This seems to be due to a multimerization process where, residues 130-132, the DDQ loop, from one molecule is inserted into the, active site of the neighboring molecule, resulting in a continuous string, of interacting TC-PTP molecules. Importantly, despite the high degree of, functional and structural similarity between TC-PTP and PTP1B, we have, been able to identify areas close to the active site that might be, addressed to develop selective inhibitors of each enzyme.
+
Protein-tyrosine phosphatase 1B (PTP1B) has recently received much attention as a potential drug target in type 2 diabetes. This has in particular been spurred by the finding that PTP1B knockout mice show increased insulin sensitivity and resistance to diet-induced obesity. Surprisingly, the highly homologous T cell protein-tyrosine phosphatase (TC-PTP) has received much less attention, and no x-ray structure has been provided. We have previously co-crystallized PTP1B with a number of low molecular weight inhibitors that inhibit TC-PTP with similar efficiency. Unexpectedly, we were not able to co-crystallize TC-PTP with the same set of inhibitors. This seems to be due to a multimerization process where residues 130-132, the DDQ loop, from one molecule is inserted into the active site of the neighboring molecule, resulting in a continuous string of interacting TC-PTP molecules. Importantly, despite the high degree of functional and structural similarity between TC-PTP and PTP1B, we have been able to identify areas close to the active site that might be addressed to develop selective inhibitors of each enzyme.
==Disease==
==Disease==
Line 17: Line 17:
[[Category: Protein-tyrosine-phosphatase]]
[[Category: Protein-tyrosine-phosphatase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Iversen, L.F.]]
+
[[Category: Iversen, L F.]]
[[Category: protein tyrosine phosphatase]]
[[Category: protein tyrosine phosphatase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:16:59 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:42:29 2008''

Revision as of 11:42, 21 February 2008


1l8k, resolution 2.56Å

Drag the structure with the mouse to rotate

T Cell Protein-Tyrosine Phosphatase Structure

Contents

Overview

Protein-tyrosine phosphatase 1B (PTP1B) has recently received much attention as a potential drug target in type 2 diabetes. This has in particular been spurred by the finding that PTP1B knockout mice show increased insulin sensitivity and resistance to diet-induced obesity. Surprisingly, the highly homologous T cell protein-tyrosine phosphatase (TC-PTP) has received much less attention, and no x-ray structure has been provided. We have previously co-crystallized PTP1B with a number of low molecular weight inhibitors that inhibit TC-PTP with similar efficiency. Unexpectedly, we were not able to co-crystallize TC-PTP with the same set of inhibitors. This seems to be due to a multimerization process where residues 130-132, the DDQ loop, from one molecule is inserted into the active site of the neighboring molecule, resulting in a continuous string of interacting TC-PTP molecules. Importantly, despite the high degree of functional and structural similarity between TC-PTP and PTP1B, we have been able to identify areas close to the active site that might be addressed to develop selective inhibitors of each enzyme.

Disease

Known diseases associated with this structure: Diabetes mellitus, insulin-dependent, susceptibility to OMIM:[600716], Rheumatoid arthritis, susceptibility to OMIM:[600716], Systemic lupus erythematosus, susceptibility to OMIM:[600716]

About this Structure

1L8K is a Single protein structure of sequence from Homo sapiens. Active as Protein-tyrosine-phosphatase, with EC number 3.1.3.48 Full crystallographic information is available from OCA.

Reference

Structure determination of T cell protein-tyrosine phosphatase., Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S, Mortensen SB, Moller NP, J Biol Chem. 2002 May 31;277(22):19982-90. Epub 2002 Mar 20. PMID:11907034

Page seeded by OCA on Thu Feb 21 13:42:29 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools